As mentioned previously, DVL can bind AXIN and inhibit its activity (3), thus dissociating the axin-assembled beta-catenin destruction complex by displacing AXIN, or by recruiting another protein called FRAT (frequently rearranged in advanced T-cell lymphomas). This evidence concerns the gene AXIN1 and T-cell non-Hodgkin lymphoma.